Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: A clinical review

Journal of Parkinson's Disease

Volumn 2, Issue 2, 2012, Pages 135-151

  Armento, Maria E A ^a,b,c   Stanley, Melinda A ^a,b,c   Marsh, Laura ^b,d   Kunik, Mark E ^a,b,c   York, Michele K ^b,d   Bush, Amber L ^a,b   Calleo, Jessica S ^a,b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Education   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

anxiety; CBT; depression; Parkinson's disease

Indexed keywords

CITALOPRAM; DESIPRAMINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY DISORDER; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; HUMAN; MOOD DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

ANXIETY; COGNITIVE THERAPY; DATABASES, BIBLIOGRAPHIC; DEPRESSION; FEMALE; HUMANS; MALE; PARKINSON DISEASE;

EID: 84864663188     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-2012-12080     Document Type: Review

References (89)

1. de Lau LML, & Breteler MMB (2006) Epidemiology of Parkinson's disease. Lancet Neurol, 5, 525-535.
2. Lang AE, & LozanoM(1998) Parkinson's disease. New Engl J Med, 339, 1130-1143.
3. Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, & Cummings JL (1999) Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry, 67, 492-496.
4. Rahman S, Griffin HJ, Quinn NP, & Jahanshahi M (2008) Quality of life in Parkinson's disease: The relative importance of the symptoms. Mov Disord, 23, 1428-1434.
5. Shulman LM, Taback RL, Rabinstein AA, & Weiner WJ (2002) Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord, 13, 545.
6. Reidel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, OertelW, Reichmann H, Reiderer P, Trenkwalder C, Dodel R, & Wittchen HU (2010) Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol, 257, 1073-1082.
7. Martínez-Martin P, Rodriguez-Blazquez BS, Kurtis MM, Chaudhuri KR, NMSS Validation, Group (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord, 26, 399-406.
8. Global Parkinson's Disease Survey Steering, Committee (2002) Factors impacting on quality of life in Parkinson's disease: Results from an international survey. Mov Disord, 17, 60-67.
9. Weintraub D, Moberg PJ, Duda JE, Katz IR, & Stern MB (2004) Effects of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc, 52, 784-788.
10. Calne SM (2003) The psychosocial impact of late-stage Parkinson's disease. J Neurosci Nurs, 35, 306-313.
11. Quelhas R, & CostaM(2009) Anxiety, depression, and quality of life in Parkinson's disease. J Neuropsychiatry Clin Neurosci, 21, 413-419.
12. Carod-Artal FJ, Ziomkowski S, Mesquita HM, & Martýnez-Martin P (2008) Anxiety and depression: Main determinants of health-related quality of life in Brazilian patients with Parkinson's disease. Parkinsonism Relat Disord, 14, 102-108.
13. Reijnders JS, Ehrt U,Weber WE, Aarsland D,&LeentjensAF (2008) A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord, 23, 183-189.
14. Dissanayaka NNW, Sellbach A, Matheson S, O'Sullivan JD, Silburn PA, Byrne GJ, Marsh R, & Mellick GD (2010) Anxiety disorders in Parkinson's disease: Prevalence and risk factors. Mov Disord, 25, 838-845.
15. Pontone GM,Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV,Weiss HD, &Marsh L (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord, 24, 1333-1338.
16. Menza MA, Robertson-Hoffman DE,& Bonapace AS (1993) Parkinson's disease and anxiety: Comorbidity with depression. Biol Psychiatry, 34, 465-470.
17. Nuti A, Ceravolo R, Piccinni A, Dell'Angello G, Bellini G, Gambaccini G, Rossi C, Logi C, Dell 'Osso L, & Bonicelli U (2004) Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol, 11, 315-320.
18. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.). American Psychiatric Association, Arlington, VA.
19. Edwards E, Kitt C, Oliver E, Finkelstein J, Wagster M, & McDonald WM (2002) Depression and Parkinson's disease: A new look at an old problem. Depress Anxiety, 16, 39-48.
20. Barone P, Goetz CG, Houben JJ, Koester J, Leentjens AF, PoeweW, Rascol O, Reichmann H, Schapira AH, & Tolosa E (2007) PRODEST- Depressive symptoms in Parkinson's disease: Demographic data. Presentation at the 11th Congress of the European Federation of Neurological Societies in Brussels, Belgium.
21. Skidmore FM, Yang M, Baxter L, von Deneen K, Collingwood J, He G, Tandon R, Korenkevych D, Savenkov A, Heilman KM, Gold M, & Liu Y (2011) Apathy, depression and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease. Neuroimage.
22. Lieberman A (2006) Depression in Parkinson's disease- a review. Acta Neurologica Scandinavica, 113, 1-8.
23. Erdal KJ (2001) Depression and anxiety in persons with Parkinson's disease with and without the "on-off" phenomena. J Clin Psychol Med Settings, 8, 293-299.
24. Nègre-Pagès L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lépine JP, Rascol O, DoPaMiP Study Group (2010) Anxious and depressive symptoms in Parkinson's disease: The French cross-sectional DoPaMiP study. Mov Disord, 25, 157-166.
25. Calleo J, Bush AL, Williams JR, Hirsch ER, Anderson K, Goldstein SR, Grill S, Lehmann S, Little JT, Margolis L, Palanci J, Pontone G, Weiss H, Rabins P, & Marsh L (2011) Screening accuracy of comorbid anxiety and depression in Parkinson's disease. Presentation at the Twentyfifth Annual Parkinson's Study Group Symposium, Irving, TX.
26. Aarsland D, Marsh L, & Schrag A (2009) Neuropsychiatric symptoms in Parkinson's disease. Mov Disord, 24, 2175-2186.
27. Lang AE, & Lees A (2002) Management of Parkinson's disease: An evidence-based review. Mov Disord, 17(suppl. 4), i.
28. Veazey C, Aki SOE, Cook KF, Lai EC, & Kunik ME (2005) Prevalence and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci, 17, 310-323.
29. Arun MP, Bharath S, Pal PK, & Singh G (2011) Relationship of depression, disability, and quality of life in Parkinson's disease: A hospital-based case-control study. Neurol India, 59, 185-190.
30. Richard IH, & Kurlan R (1997) A survey of antidepressant drug use in Parkinson's disease. Neurology, 49, 1168-1170.
31. Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, Bienfait K, & Dicke A (2009) A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology, 72, 886-892.
32. Devos D, Dujardin K, Poirot I, Moreau C, Cottencin O, Thomas P, Destée A, Bordet R,&Defebvre L (2008) Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebocontrolled study. Mov Disord, 23, 850-857.
33. Richard IH, McDermott M, & McDonald WM (in press) A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine and venlafaxine extended release for depression in Parkinson's disease. Neurology.
34. Ghazi-Noori S, Chung TH, Deane K, Rickards HE, & Clarke CE (2009) Therapies for depression in Parkinson's disease. Cochrane Database of Systematic Reviews, Issue 2, Art. No.: CD003465. DOI: 10.1002/14651858.CD003465; edited, 2009.
35. Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano Ramos C, Brodsky M, Manning C, Marsh L, Shulman L, Ferenandez HH, Black KJ, Panisset M, Christine CW, Jiang W, Singer C, Horn S, Pfeiffer R, Rottenberg D, Slevin J, Elmer L, Press D, Hyson HC, & McDonald W (2012) A randomized, doubleblind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology, 78, 1229-1236.
36. Dobkin RD, Menza A, Bienfait KL, Gara M, Marin H, Mark MH, DickeA,&Friedman J (2011) Depression in Parkinson's disease: Symptom improvement and residual symptoms after acute pharmacologic management. Am J Geriatr Psychiatry, 19, 222-229.
37. Palanci J, Marsh L, & Pontone GM (in press) Gaps in treatment for anxiety in Parkinson disease. Am J Geriatr Psychiatry.
38. Menza M, Marin H, Kaufman K, Mark M, & Lauritano M (2004) Citalopram treatment of depression in Parkinson's disease: The impact on anxiety, disability, and cognition. J Neuropsychiatry Clin Neurosci, 16, 315-319.
39. Chaudhuri KR, Healy DG, & Schapira AHV (2006) Nonmotor symptoms of Parkinson's disease: Diagnosis and management. Lancet Neurol, 5, 235-245.
40. Frisina PG, Borod JC, Foldi NS, & Tenenbaum HR (2008) Depression in Parkinson's disease: Health risks, etiology, and treatment options. Neuropsychiatr Dis Treat, 4, 81-91.
41. Cole K, & Vaughan FL (2005) The feasibility of using cognitive behavioral therapy for depression associated with Parkinson's disease: A literature review. Parkinsonism Relat Disord, 11, 269-276.
42. American Psychiatric, Association (2010) Practice Guideline and Resources for Treatment of Patients with Major Depressive Disorder, Third edition. doi: 10.1176/appi.books.9780890423370.661052. Available at http://psychiatryonline. org/guidelines.aspx. Accessed Apri 15, 2012.
43. Schneider F, Althaus A, Backes V, & Dodel R (2008) Psychiatric symptoms in Parkinson's disease. Eur Arch Psychiatry Clin Neurosci, 258(suppl. 5), 55-59.
44. Oehlberg K, Barg FK, Brown GK, Taraborelli D, Stern MB, & Weintraub D (2008) Attitudes regarding the etiology and treatment of depression in Parkinson's disease: A qualitative study. J Geriatr Psychiatry Neurol, 21, 123-132.
45. Dobkin RD, Menza M, & Bienfait KL (2008) CBT for the treatment of depression in Parkinson's disease: A promising non-pharmacological approach. Expert Rev Neurother, 8, 27-35.
46. Goetz CG (2010) New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease. Mov Disord, 25, S104-S109.
47. Dreissen E, & Hollon SD (2010) Cognitive behavioral therapy for mood disorders: Efficacy, moderators and mediators. Psychiatr Clin North Am, 33, 537-555.
48. Young JE, Rygh JL, Weinberger AD, & Beck AT (2008) Cognitive therapy for depression. In Clinical Handbook of Psychological Disorders (4th ed.), Barlow DH, ed. Guilford Press, New York, pp. 250-305.
49. Hunot V, Churchill R, Silva de lima M, & Teixeira V (2007) Psychological therapies for generalized anxiety disorder. Cochrane Database of Systematic Reviews, CD001848.
50. Craske MG, & Barlow DH (2008) Panic disorder and agoraphobia. In Clinical Handbook of Psychological Disorders (4th ed.), Barlow DH, ed. Guilford Press, New York, pp. 1-64.
51. Turk CL, Heimberg RG, & Magee L (2008) Social anxiety disorder. In Clinical Handbook of Psychological disorders (4th ed.), Barlow DH, ed. Guilford Press, New York, pp. 123-163.
52. Franklin ME,&Foa E (2008) Obsessive-compulsive disorder. In Clinical Handbook of Psychological Disorders (4th ed.), Barlow DH, ed. Guilford Press, New York, pp. 164-215.
53. American Psychiatric Association (2010) Understanding Anxiety Disorders and Effective Treatment, http://www.apa.org/helpcenter/anxiety-treatment.aspx.
54. Hopko DR, Bell JL, Armento MEA, Robertson SMC, Mullane C, Wolf N, & Lejuez CW (2008) Cognitive-behavior therapy for depressed cancer patients in a medical care setting. Behav Ther, 39, 126-136.
55. Himelhoch S, Mohr D, Maxfield J, Clayton S, Weber E, Medoff D, & Dixon L (2011) Feasibility of telephonebased cognitive behavioral therapy targeting major depression among urban dwelling African-American people with cooccurring HIV. Psychol Health Med, 16, 156-165.
56. Bernardy K, Füber N, Köllner V,&HäuserW(2010) Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome- a systematic review and metaanalysis of randomized controlled trials. J Rheumatol, 37, 1991-2005.
57. Voet NB, Bleijenberg G, Padberg GW, van Engelen BG, & Geurts AC (2010) Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: Protocol of the FACTS-2-FSHD trial. BMC Neurol, 10, 56.
58. Cully JA, Stanley MA, Deswal A, Hanania NA, Phillips LL, &KunikME(2010) Cognitive-behavioral therapy for chronic cardiopulmonary conditions: Preliminary outcomes from an open trial. Prim Care Companion J Clin Psychiatry, 12(4), e1-e6.
59. Hynninen MJ, Bjerke N, Pallesen S, Bakke PS,&Nordhus IH (2010) A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med, 104, 986-994.
60. Stanley MA, Veazey C, Hopko DR, Diefenbach G, & Kunik M (2005) Anxiety and depression in chronic obstructive pulmonary disease (COPD): A new intervention and case report. Cogn Behav Pract, 12, 424-436.
61. Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, Carter R, Sharafkhaneh A, Goepfert EJ, Wray N, & Stanley MA. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: A randomized controlled trial. Psychol Med, 38, 385-396.
62. CDR(Centre for Reviews and Dissemination) (2009). Systematic Reviews. CRD, University of York, Layerthorpe, York.
63. Dobkin RD, Allen LA, & Menza M (2006) A cognitivebehavioral treatment package for depression in Parkinson's disease. Psychosomatics, 47, 259-263.
64. Gupta R (2000) Treatment of depression in an elderly Asian Indian male: A cognitive behavioral approach. Clin Gerontol, 22, 87-90.
65. Cole K, & Vaughan FL (2005) Brief cognitive behavioural therapy for depression associated with Parkinson's disease: A single case series. Behav Cogn Psychother, 33, 89-102.
66. Mackin RS, Aréan P, & Elite-Marcandonatou A (2006) Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: A case study. Neuropsychiatr Dis Treat, 2, 375-379.
67. Heinrichs N, Hoffman EC,&Hofmann SG (2001) Cognitivebehavioral treatment for social phobia in Parkinson's disease: A single-case study. Cogn Behav Pract, 8, 328-335.
68. Mohlman J, Reel DH, Chazin D, Ong D, Georgescu B, Tiu J, &DobkinRD(2010)Anovel approach to treating anxiety and enhancing executive skills in an older adult with Parkinson's Disease. Clin Case Stud, 9, 74-90.
69. Macht M, Pasqualini MS, & Taba P (2007) Cognitivebehavioral strategies for Parkinson's disease:Areport of three cases. J Clin Psychol Med Settings, 14, 165-176.
70. Feeney F,Egan S,&GassonN(2005)Treatment of depression and anxiety in Parkinson's disease: A pilot study using group cognitive behavioural therapy. Clin Psychol, 9, 31-38.
71. Dreisig H, Beckmann J, Wemuth L, Skovlund S, & Bech P (1999) Psychologic effects of structured cognitive psychotherapy in young patients with Parkinson disease: A pilot study. Nord J Psychiatry, 53, 217-221.
72. Dobkin RD, Allen LA, & Menza M (2007) Cognitivebehavioral therapy for depression in Parkinson's disease: A pilot study. Mov Disord, 7, 946-952.
73. Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, & Alpert JE (2010) Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics, 51, 124-129.
74. Dobkin RD, Menza M, Allen LA, Tiu J, Friedman J, Bienfait KL, Gara MA, & Mark MH (2011) Telephone-based cognitive-behavioral therapy for depression in Parkinson disease. J Geriatr Psychiatry Neurol, 24, 206-214.
75. Ellgring H, Seller S, Perleth B, Gasser T, & Oertel W (1990) An integrated approach for the neurological and psychological support of parkinson patients. New Trends in Clinical Neuropharmacology, IV, 31-34.
76. Veazey C, Cook KF, StanleyM, Lai EC, & Kunik ME (2009) Telephone-administered cognitive behavioral therapy: A case study of anxiety and depression in Parkinson's disease. J Clin Psychol Med Settings, 16, 243-253.
77. Dobkin RD, Menza M, Allen LA, Gara MA, Mark MH, Tiu J, Bienfait KL, & Friedman J (in press) Cognitive behavior therapy for depression in Parkinson's disease: A randomized controlled trial. Am J Psychiatry.
78. Pontone GM,Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, & Marsh L (2011) Anxiety and selfperceived health status in Parkinson's disease. Parkinsonism and Related Disorders, 17, 249-254.
79. Ishihara-Paul L,Wainwright WJ, KhawKT, Luben RN,Welch AA, Day NE, Brayne C, & Surtees PG (2008) Prospective association between emotional health and clinical evidence of Parkinson's disease. European Journal of Neurology, 15, 1148-1154.
80. Schrag A (2006) Quality of life and depression in Parkinson's disease. J Neurol Sci, 248, 151-157.
81. Montel S, Bonnet A, & Bungener C (2009) Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease. J Geriatr Psychiatry Neurol, 22, 95-102.
82. Secker DL, & Brown RG (2010) Cognitive behavioural therapy (CBT) for carers of patients with Parkinson's disease: A preliminary randomized controlled trial. J Neurol Neurosurg Psychiatry, 76, 491-497.
83. Alexopoulos GS, Raue PJ, Kiosses DN, Mackin RS, Kanellopoulos D, McCulloch C,&Arean PA(2011) Problemsolving therapy and supportive therapy in older adults with major depression and executive dysfunction. Arch Gen Psychiatry, 68, 33-41.
84. Kiosses D, Arean PA, Teri L, & Alexopoulos GS (2010) Home-delivered Problem Adaptation Therapy (PATH) for depressed, cognitively impaired, disabled elders: A preliminary study. Am J Geriatr Psychiatry, 18, 988-998.
85. Paukert AL, Calleo J, Kraus-Schuman C, Snow L,Wilson N, Petersen NJ,KunikME,&StanleyMA(2010) Peaceful Mind: An open trial of cognitive - behavioral therapy for anxiety in persons with dementia. Int Psychogeriatr, 22, 1012-1021.
86. Mohlman J, Chazin D, & Georgescu B (2011) Feasibility and acceptance of a nonpharmacological cognitive remediation intervention for patients with Parkinson disease. J Geriatr Psychiatry Neurol, 24, 91-97.
87. Calleo J, Burrows C, Levin H, Marsh L, Lai E, & York MK (2012) Cognitive Rehabilitation for executive dysfunction in Parkinson's disease: Application and current directions. Parkinson's Disease, 2012, 1-6.
88. Hayes SC, Strosahl KD,&WilsonKG(2003) Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change. The Guilford Press, New York, NY.
89. Blackledge JT, & Hayes SC (2001) Emotion regulation in Acceptance and Commitment Therapy. JCLP/In Session: Psychotherapy in Practice, 57, 243-255.